Logistics/Distribution

This page is under construction and edited by Ruth Donners EMBA09. In case of any questions/remarks, feel free to contact me

Description:

This driving force is currently written to support the scenario The Future of R&D in Pharmaceutical Industry in 2025. This relates to the possibility to expand in new markets by pharmaceutical industries, especially in developing countries, where logistics and distribution may be a hurdle to get the drug to the patient.

Enablers:

• The increasing globalization of markets
• Increasing Power of the United Nations
• Unification of regulatory approval
• Effect of development of health care system in emerging market countries to existing pharmaceutical industry
• Good distribution network, also IT-wise

Inhibitors:

• Protectionism, eg. very high import duties, difficult regulatory demands before drug is approved
• Corruption, eg. in getting the drug imported and transported to the proper place
• The increasing gap between developed, emerging and poor economies
• Lack of proper roads and transport
• Lack of knowlegde of patients

Paradigms:

• Starting to count on developing countries or emerging markets to make pharma grow needs the drugs to reach the patients
• Distribution and logistics are essential to get the drug to the patient
• In many ways there are still a lot of places people don't easlily reach

Experts:

• United Nations, eg. World Health Organisation
• National regulatory bodies
• National governments regarding availability of roads, public transport, distribution channels
• World Trade Organisation, regarding import tarifs

Timing:

Dates for key milestones in the development of the driving force.

Web Resources:

Useful resources on the web relating to this force.